Switching from tenofovir disoproxil fumarate to tenofovir alafenamide in antiretroviral regimens for virologically suppressed adults with HIV-1 infection: a randomised, active-controlled, multicentre, open-label, phase 3, non-inferiority study
Titel:
Switching from tenofovir disoproxil fumarate to tenofovir alafenamide in antiretroviral regimens for virologically suppressed adults with HIV-1 infection: a randomised, active-controlled, multicentre, open-label, phase 3, non-inferiority study
Auteur:
Mills, Anthony Arribas, Jose R Andrade-Villanueva, Jaime DiPerri, Giovanni Van Lunzen, Jan Koenig, Ellen Elion, Richard Cavassini, Matthias Madruga, Jose Valdez Brunetta, Jason Shamblaw, David DeJesus, Edwin Orkin, Chloe Wohl, David A Brar, Indira Stephens, Jeffrey L Girard, Pierre-Marie Huhn, Gregory Plummer, Andrew Liu, Ya-Pei Cheng, Andrew K McCallister, Scott